KALA BIO receives Nasdaq delisting notice for bid price below $1.00

KALA BIO, Inc.

On Aug 27, 2026, Nasdaq notified KALA that bid price was below $1.00 for 30 consecutive business days (Jul 16–Aug 26, 2026).
Company ineligible for 180-day compliance period due to 1-for-50 reverse stock split effected May 11, 2026.
KALA intends to timely request a hearing before the Nasdaq Hearings Panel to appeal the determination.
A timely hearing request stays suspension or delisting pending the Panel's decision; no assurance of continued listing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.